ArticleBMC medical imaging2026
The diagnostic value of virtual unenhanced spectral CT images in acute pancreatitis: a comparison with true unenhanced images.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate whether virtual unenhanced (VUE) images generated from spectral CT using the rapid kVp switching technique can serve as a substitute for true unenhanced (TUE) images in the assessment of acute pancreatitis (AP).
methodsThis retrospective study included 90 patients diagnosed with AP according to the Revised Atlanta Classification who underwent unenhanced non-spectral CT scan and dual-phase spectral CT scans of the abdomen. VUE images for the arterial (AP-VUE) and venous phases (VP-VUE) were reconstructed using material decomposition techniques. Objective and subjective assessments were conducted on TUE, AP-VUE, and VP-VUE images. The objective evaluation included CT attenuation, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). The subjective evaluation was performed by three readers independently and assessed image quality, lesion identification, severity grading of pancreatitis, and diagnostic confidence.
resultsCT attenuations differences between the TUE and VUE images were not significant for AP lesion (P = 0.110 (Pancreatitis) & 0.052 (Peripancreatic effusion)), with over 76.67% of anatomical regions showing differences within 10 HU. Compared with VP-VUE and AP-VUE images, TUE images demonstrated higher SNR and CNR overall. Diagnostic confidence scores were comparable across TUE, AP-VUE, and VP-VUE (confidence scores from 5(4, 5) to 5(5, 5), P from 0.439 to 1.000) and the diagnostic conclusions showed no significant differences as well (P > 0.05). The Balthazar CT grading system (A–E) demonstrated high concordance (Intraclass correlation coefficients > 0.8) across all image types, with no difference in AP severity assessment (P > 0.05).
conclusionThe diagnostic value of VUE images in AP is comparable to that of TUE images, suggesting that VUE images can serve as an alternative to reduce radiation exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.